Connect with us

Business

Advanced Biologics Coy, Atunse Healthcare Opens in Lagos

Published

on

Atunse Healthcare Limited has launched in Lagos with a commitment to manufacture and distribute advanced regenerative biologics.

Biztellers reports that the African-led enterprise would also be training scientists and clinicians required to optimise the use of the products, so that Nigerians no longer have to leave the country for advanced medicine.

In a statement on Friday, the company averred that for a generation, the most advanced medicine available has been something Nigerians travelled for — if they could afford the journey.

ALSO READ: NMDPRA Moots New Policy to Improve Energy Security, Stem Fuel Price-fixing

It was gathered that Atunse was established on the position that they should not have to, and that the capability to deliver and eventually produce such medicine belongs on the continent rather than at the end of an import chain.

The company is already treating patients across six service lines: aesthetic medicine, longevity and vitality, men’s wellness, women’s wellness, musculoskeletal support and neurological care.

It stated that “Africa imports approximately 99% of the vaccines and more than 95% of the medicines it uses, producing under 1% of its own vaccine supply. The cost of that dependency is visible in Nigeria: an estimated US$2.39 billion left the country in 2024 with citizens seeking care abroad.”

It added that “the greater cost is borne by those who cannot travel, and for whom advanced treatment has simply not been an option. Against this backdrop, the launch of Atunse Healthcare reflects a growing case for building the infrastructure, expertise and partnerships needed to strengthen Nigeria’s health sovereignty.

At the launch, the keynote speaker, Alh Aliko Dangote, President and Chief Executive Officer of the Dangote Group, represented by Fatima Aliko Dangote, Group Executive Director of Commercial Operations for Oil & Gas, Dangote Industries, pointed out that the COVID-19 pandemic demonstrated the risks of relying heavily on external sources for essential health technologies.

“COVID-19 taught us a very important lesson: dependence is a vulnerability,” he said. “For us in Africa, medical sovereignty cannot just be a slogan. It is about building the capacity to protect our people.”

He described initiatives such as Atunse as important steps towards changing Africa’s position from being predominantly a consumer of advanced medicine to becoming a producer, noting that Nigeria has the talent, entrepreneurial energy and market needed to build that capability.

He added that the future of healthcare cannot be built by government or the private sector acting alone, but through partnerships that bring together policy, investment, science, enterprise and innovation.

Atunse Healthcare Ltd. is a partnership between KweHealth, LLC of the United States, which contributes an established scientific and manufacturing platform, and Tri-State Healthcare System of Nigeria, which contributes clinical delivery and institutional depth. The company is Nigerian-domiciled and Nigerian-based.

It is building four capabilities together rather than in sequence: clinical delivery through a treatment centre in Nigeria; advanced biomanufacturing, working towards cGMP-grade production of advanced biologics in Nigeria, with a roadmap extending to vaccines and, in time, cell and gene therapies; research and clinical translation, so that discovery and evidence generation take place in Africa and African patients are participants in the science rather than only recipients of its outputs; and regulatory capability, developed in active alignment with NAFDAC on the pathway for advanced biologic products.

Local manufacturing carries a workforce consequence the company treats as central rather than incidental. Biomanufacturing, quality assurance, regulatory science and clinical research are high-skill, durable roles, and Nigeria has few of them because it has had little to practise them on.

Atunse’s position is that a country which manufactures without training its own scientists, and without governing its own standards, has substituted one dependency for another.

Lagos State Governor, Mr. Babajide Sanwo-Olu, represented by Prof. Akin Abayomi, Lagos State Commissioner for Health, at the event, emphasised the importance of building the specialist workforce needed to support the growth of advanced healthcare in Nigeria.

He said initiatives such as Atunse could help create the kind of environment capable of attracting experienced Nigerian doctors and scientists working abroad back home.

“When we start seeing initiatives like this, it starts to encourage our own experienced specialists to come back home,” Gov. Sanwo-Olu said. “This is the kind of initiative that is attractive to doctors and scientists doing great things abroad.”

He noted that regenerative medicine represents an important frontier for healthcare and stressed the need to build the institutions, skills, data infrastructure and systems required to take advantage of emerging opportunities.

“Government cannot do this alone,” he said. “We need the universities, the researchers, the healthcare providers and the private sector working together. Our role is to create the environment and the systems that allow that innovation to happen and, ultimately, improve the health of our people.”

Gov. Sanwo-Olu also highlighted the importance of data and digital infrastructure in developing a health system capable of responding to both current and future needs, noting the role of Lagos State’s Smart Health Information Platform (SHIP) in digitalising public health facilities and the opportunity for private-sector participation.

Atunse’s workforce ambition is therefore tied directly to its manufacturing and clinical ambitions. The company intends to build capability locally rather than simply establish another route for importing advanced products. The African Union has committed the continent to producing 60% of its own health products locally by 2040.

Atunse works with four investigational platforms developed and manufactured by KweHealth — AVEXO™, KH-1814™, AIOVA™ and NKIRA™. These are used only within approved regulatory and ethical frameworks and with informed consent. They are not approved for any indication, and the company makes no claim of safety or efficacy.

“For a generation, the most advanced medicine of our age has been something Africans travel for. Atunse exists to change the direction of that journey. We begin in Lagos, but what we are building is not for Lagos alone,” said Prof. Kamar T. Adeleke, President and Chairman, Atunse Healthcare Ltd.

Dr. Sola Oluwole, Chief Executive Officer, Atunse Healthcare Ltd., said the company’s ambition extends beyond keeping healthcare spending within Nigeria.

“What Nigeria loses is not only money. It is the demand, the capital and the clinical talent that need never have left. That is not a shortage of resources — it is an absence of capability. We intend to build it here: the treatment, the manufacturing, the distribution, and the people who will run all three.”

Dr. Frederick A. Kweh, Chief Science and Technology Officer, Atunse Healthcare Ltd., added: “Africa is not asking to be admitted to this field. It is joining it — as a manufacturer and as a clinical partner, working on the health problems this continent actually has.”

The launch brings together Atunse’s immediate clinical operations with its longer-term ambition to establish an African platform for advanced medicine — one that combines treatment, manufacturing, research, regulation and workforce development.

Business

Guinness Nigeria CEO Shares Sustainable Growth Strategy

Published

on

Guinness Nigeria Plc is focused on sustaining growth through wider product availability, commercial expansion and disciplined pricing.

Managing Director and Chief Executive Officer, Guinness Nigeria, Girish Sharma made the disclosure in an interview with CNBC Africa, in which he outlined the priorities expected to shape the company’s performance in the coming quarters.

According to Sharma, the company would keep focusing on making its products more accessible to consumers while strengthening its presence across markets and distribution channels.

“The strategy has always been growing by being available at more places, having our beer, having our products cold in a lot of places and ensuring that we are playing at the right price points,” he said.

READ ALSO: Osun Tackles Sanitation with Adhoc Road Sweepers

Sharma explained that the company’s approach was centred on expanding its reach rather than relying on price increases to drive growth.

He said Guinness Nigeria had increased the number of locations and cities in which its products were available, alongside growth in its distributor network.

He maintained that the company’s commercial expansion is part of a longer-term plan that will continue over the next three to five years.

“In terms of number of touch points where we’re available to the Guinness Nigeria products, number of cities where we’re available today, number of distributors that we have that distribute our products today, on every single count we have grown multi-fold,” Sharma said.

He described the expansion as a significant undertaking for the business, noting that the effort began with his first 100-day plan and remains a key part of the company’s direction.

Sharma also pointed to operational discipline and improvements made over the past year as important foundations for the business. He said earlier decisions to address the balance sheet, adjust pricing and make fundamental corrections were now supporting the company’s growth trajectory.

He added that teams across operations and procurement were working to keep price increases to a minimum while increasing output, while a more stable currency environment had also been helpful.

Looking ahead, Sharma said the company would focus on maintaining consistency rather than promising a particular growth rate for the next quarter.

“I’m not here to stand and say that we’re going to do better than the third quarter, but what I see is we will be consistent in terms of delivering healthy results,” he said. “Consistency is the word.”

He also highlighted the importance of the final quarter of the year to the beverage industry, citing increased consumer activity around the festive season. Guinness Nigeria, he said, had strategic partnerships planned across the period, with some extending into the first quarter of the following year.

Sharma said the company’s broader ambition was to build a stronger business capable of funding its growth, rewarding shareholders and sustaining performance over time.

“The business is sturdy, business is strong, business is good, and I’m confident that we will continue to grow sustainably,” he said.

His comments underline Guinness Nigeria’s focus on extending its market reach, strengthening execution and building consistency as it pursues its longer-term growth ambitions.

Continue Reading

Business

NLNG: Nigeria’s Oil Ambitions Require Investor Guarantees

Published

on

Nigeria must be surefooted to attract the right investment to harness her full potential in the oil and gas industry.

At the 32nd Nigerian Economic Summit (NES) during a panel session titled, “Unlocking Nigeria’s Oil Potential: The Push for More Oil”, in Abuja, the Managing Director and Chief Executive Officer of NLNG, Adeleye Falade, decried the lack of certainties in the investment environment in Nigeria’s oil industry.

He traced Nigeria’s inability to attract sufficient financing for major oil and gas projects to uncertainties over investment terms, project execution and guaranteed markets for output.

According to Falade, investors and lenders must be confident that contractual agreements will be honoured, projects will deliver as planned and buyers will be available to purchase production before committing billions of dollars to capital-intensive energy developments.

READ ALSO: OTL Africa Urges ECOWAS to Adopt Regional Standardisation

He cited the financing of NLNG’s Train 7 expansion as evidence that investment certainty, a proven delivery record and credible commercial agreements could unlock substantial funding, even under challenging global economic conditions.

Falade explained that projects requiring huge upfront capital and 20 to 30 years to recover investments depend on confidence that the terms underpinning them will remain stable throughout their lifespan.

According to him, lenders assess not just the quality of an oil or gas resource but also the durability of the investment framework, the predictability of future earnings and the capacity of project sponsors to meet their obligations.

Falade pointed to the $3 billion in external financing secured from 31 local and international financial institutions for Train 7 in 2020, at the height of the COVID-19 pandemic, as proof of the importance of a credible investment proposition.

The project is being financed through a combination of internally generated cash flows and external funding, underpinned by NLNG’s record of developing six operating trains and repaying the loans used to finance their construction.

He said that track record gave lenders tangible evidence of the company’s capacity to execute complex projects and honour financial commitments, reducing the uncertainty that often discourages investment in capital-intensive developments.

He noted that each successful expansion strengthened NLNG’s credibility and positioned it to secure subsequent financing on more competitive terms.

He identified three fundamental questions that lenders seek answers to before financing major energy projects: “Who buys the product? Who carries the risk? Who stands behind the project?”

For NLNG, he said, long-term sales and purchase agreements, some spanning 20 years, provide the commercial foundation required to secure funding before a final investment decision is taken.

Continue Reading

Business

OTL Africa Urges ECOWAS to Adopt Regional Standardisation

Published

on

A call has gone to West African countries to adopt uniform fuel specifications, strengthen testing capacity, address infrastructure gaps and improve enforcement systems to facilitate more effective regional petroleum trade.

This formed the bulk of the submission of petroleum regulators at a panel session during the 20th OTL Africa Downstream Energy Week that ended in Lagos.

It is the considered opinion of the regulators that inconsistencies in standards across the region remain a huge disservice to fair competition. Therefore, they expressed a common view that putting in place an acceptable standard will ensure a harmonised fuel quality, improve infrastructure and stronger regulatory coordination which will facilitate cross-border trade and reduce market barriers across the region.

Speaking at the session themed: “Regulatory Convergence in African Oil and Gas Markets,” the Authority Chief Executive (ACE), Nigerian Midstream and Downstream Petroleum Regulatory Authority (NMDPRA), Rabiu Umar, argued that differences in fuel specifications across countries made it difficult to compare products and ensure fair competition.

READ ALSO: NUPRC Resorts to Technology to Reduce Emissions by 60%

For instance, he explained that the disparity between diesel specifications of 50 parts per million (ppm) and 1,500 ppm, presents a complication in efforts to harmonise standards across the region.

To this end, the ACE said the sub regional countries needed common product specifications and coordinated production rules to facilitate trade and promote competition.

Umar also advocated the establishment of a West African reference price for petroleum products, saying regional markets needed to strengthen trade among African producers.

On his part, the Chief Executive Officer of Ghana’s National Petroleum Authority (NPA), Godwin Tameklo, said that inadequate infrastructure was a major constraint to regional petroleum trade.

According to him, countries needed to address infrastructure gaps, regulatory differences and market constraints to improve the cross-border movement of petroleum products.

For instance, he disclosed that Ghana’s port and storage facilities could not always accommodate volumes delivered by larger vessels, forcing operators to consider smaller shipments or alternative arrangements.

Tameklo also stressed the need for clear implementation timelines to ensure that regional harmonisation initiatives translated into practical results.

In a similar vein, the Director of Water, Petroleum and Electricity at The Gambia’s Public Utilities Regulatory Authority (PURA), Musa Njie, highlighted the importance of laboratory facilities in testing petroleum product quality.

Njie identified the absence of a laboratory for petroleum product testing as one of the challenges facing The Gambia, and stressed the need to strengthen national quality assurance systems.

He said that harmonisation efforts should protect public health and the environment while improving market efficiency.

Njie also called for stronger coordination between regional frameworks and national regulatory institutions to ensure effective implementation of agreed standards.

Continue Reading

Copyright © 2022. Biztellers, powered by Alphaxristi.

0
Would love your thoughts, please comment.x
()
x